Action Required

By clicking yes, you will reserve a ticket for:


By clicking no, you will keep your ticket for:

Would you like to make this change?



Need help? View My Agenda Instructions or contact eval@rsna.org.

How e-ticketing works

Approximately 55 courses at RSNA 2016 require e-tickets for entry. By adding an e-ticketed course to your Agenda, you are reserving an e-ticket for that course.

Your Agenda allows you to add multiple items to your calendar so you can keep track of the things that interest you. However, you can only reserve an e-ticket for one course during a given time slot. When you select an e-ticketed course that conflicts with another e-ticketed course in your Agenda, you have the option to either switch your selection or keep the e-ticket for your original selection.

By visiting your Agenda, you can view a list of your e-ticketed courses and modify your selections by adding or deleting courses from your Agenda.

You will not receive printed tickets for any of your courses. Rather, your meeting badge will be scanned at the door for admittance.

Contact myagenda@rsna.org for more information or assistance.



Certificate Of Attendance

Login is required to use the Certificate Of Attendance.

Explore more meeting programs

Looking for RSNA annual meeting materials and highlights from another year? Explore more meeting programs.
Daily Bulletin 2017

Annual Oration in Radiation Oncology Presented Today

Wednesday, Nov. 29, 2017

How Personalized Medicine will Transform Radiation Oncology

Daphne Haas-Kogan, MD, will present the Annual Oration in Radiation Oncology, entitled, "Personalized Medicine and Radiation Oncology," on Wednesday, Nov. 29, at 1:30 p.m. in Room E450A.

Haas-Kogan

Haas-Kogan

Dr. Haas-Kogan will focus on how personalized medicine has already changed radiation oncology and how it will change the specialty in the future. She will discuss the promise of radiomic imaging, which is successfully defining imaging biomarkers based on quantitative descriptions of tumor phenotypes to improve predictions of treatment response and prognosis while reducing radiation doses to organs at risk and maximizing doses to cancerous lesions.

In addition, Dr. Haas-Kogan will discuss the commitment needed from radiation oncologists to engineer drugs and design approaches that target a tumor specifically while sparing a patient's normal tissues. Finally, she will explore the new class of MRI devices that is creating a paradigm shift in radiation therapy delivery.

Dr. Haas-Kogan is chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women's Hospital and Boston Children's Hospital. She holds the Radiation Oncology Endowed Professorship at Harvard Medical School and is a member of the Association of American Physicians. She received her MD from UCSF and also completed a radiation oncology residency and post-doctoral fellowship in molecular neuro-oncology. She received a 1997 RSNA Research Scholar Grant for her work in molecular determinants of the cellular response to ionizing radiation. While at UCSF she served as vice chair for research and as educational program director.

Throughout her career, Dr. Haas-Kogan has maintained a productive, well-funded basic science laboratory in which she investigates signaling aberrations in human cancers, including adult and pediatric brain tumors. She has been the principal investigator on many grants funded by NIH/NCI, philanthropic organizations and industry collaborations.

Dr. Haas-Kogan is a member of the Blue Ribbon Panel appointed to inform the scientific direction and goals of the National Cancer Institute's Cancer Moonshot.

Tip of the day:

In CT contrast studies, lowering kVp can reduce both radiation and contrast dose.

© 2017 RSNA.
The RSNA 2017 Daily Bulletin is the official publication of the 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America. Published Sunday, November 26 — Friday, December 1.

Daily Bulletin Editorial Board and staff

The RSNA 2017 Daily Bulletin is owned and published by the Radiological Society of North America, Inc., 820 Jorie Blvd., Oak Brook, IL 60523.